Cholesterol-dependent changes of glycosaminoglycan pattern in human aorta

Basic Research in Cardiology

Volumn 91, Issue 5, 1996, Pages 344-352

  Kruse, R ^a,b   Merten, M ^b   Yoshida, K ^c   Schmidt, A ^b   Volker W ^b   Buddecke, E ^b  

^a UNIVERSITY OF BONN   (Germany)

^b UNIVERSITY OF MÜNSTER   (Germany)

^c SEIKAGAKU CORPORATION   (Japan)

Author keywords

Antiproliferative potency; Arteriosclerosis; Cholesterol content; Glycosaminoglycans; Human aorta

Indexed keywords

CHOLESTEROL; CHONDROITIN SULFATE; DERMATAN SULFATE; GLYCOSAMINOGLYCAN; HEPARAN SULFATE; HYALURONIC ACID;

ADULT; AGED; ARTERIOSCLEROSIS; ARTICLE; ELECTRON MICROSCOPY; FEMALE; HISTOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MOLECULAR WEIGHT; THORACIC AORTA;

AORTA, THORACIC; ARTERIOSCLEROSIS; CELL DIVISION; CELLS, CULTURED; CHOLESTEROL; CHONDROITIN SULFATES; DERMATAN SULFATE; GLYCOSAMINOGLYCANS; HEPARITIN SULFATE; HUMANS; MICROSCOPY, ELECTRON; MOLECULAR WEIGHT; MUSCLE, SMOOTH, VASCULAR;

EID: 0029832129     PISSN: 03008428     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Bendayan P, Boccalon H, Dupouy D, Boneu B (1994) Dermatan sulfate is a more potent inhibitor of clot bound thrombin than unfractionated and low molecular weight heparins. Thromb Haemost 71: 576-580
2. Berenson OS, Radhakrishnamurthy B, Srinivasan SR, Vijayagopal P, Dalferes ER (1985) Proteoglycans and potential mechanisms related to atherosclerosis. Ann NY Acad Sci 454: 69-78
3. Berenson GS, Radhakrishnamurthy B, Srinivasan SR, Vijayagopal P, Dalferes ER (1988) Arterial wall injury and proteoglycan changes in atherosclerosis. Arch Pathol Lab Med 112: 1002-1010
4. Bittner T, Muir H (1962) A modified uronic acid carbazole reaction. Anal Biochem 4: 330-334
5. Bocan TMA, Schifani TA, Guyton JR (1986) Ultrastructure of the human aortic fibrolipid lesion. J Pathol 123: 413-424
6. Bourin MC, Lindahl U (1993) Glycosaminoglycans and the regulation of blood coagulation. Biochem J 289: 313-330
7. Cardoso LEM, Mourào PAS (1994) Glycosaminoglycan fractions from human arteries presenting diverse susceptibilities to atherosclerosis have different binding affinities to plasma LDL. Arterioscler Thromb 14: 115-124
8. Cherchi GM, Coinu R, Demuro P, Formato M, Sanna G, Tidore M, Tira ME, De Luca G (1990) Structural and functional modifications of human aorta proteoglycans in atherosclerosis. Matrix 10: 362-372
9. Dalferes ER, Radhakrishnamurthy B, Ruiz HA, Berenson GS (1987) Compositions of proteoglycans from human atherosclerotic lesions. Exp Mol Pathol 47: 363-376
10. Davies MJ, Woolf N, Rowles P, Richardson PD (1994) Lipid and cellular constituents of unstable human aortic plaques. Basic Res Cardiol 89 Suppl 1: 33-39
11. Hollmann J, Schmidt A, von Bassewitz DB, Buddecke E (1989) Relationship of sulfated glycosaminoglycans and cholesterol content in normal and arteriosclerotic human aorta. Arteriosclerosis 9: 154-158
12. Ismail NAE, Alavi MZ, Moore S (1994) Lipoprotein-proteoglycan complexes from injured rabbit aortas accelerate lipoprotein uptake by arterial smooth muscle cells. Atherosclerosis 105: 79-87
13. Jimi S, Sakata N, Matunaga A, Takebayashi S (1994) Low density lipoproteins bind more to type I and III collagens by negative charge mechanisms than to type IV and V collagen. Atherosclerosis 107: 109-116
14. Kjellén L, Lindahl U (1991) Proteoglycans: Structure and interactions. Annu Rev Biochem 60: 443-475
15. Lévesque H, Girard N, Maingonnat C, Delpech A, Chauzy C, Tayot J, Courtois H, Delpech B (1994) Localization and solubilization of hyaluronan and of the hyaluronan binding protein hyaluronectin in human normal and arteriosclerotic arterial walls. Atherosclerosis 105: 51-62
16. Marcum JA, Atha DH, Fritze LMS, Nawroth P, Stern D, Rosenberg RD (1986) Cloned bovine aortic endothelial cells synthesize anticoagulantly active heparan sulfate proteoglycan. J Biol Chem 261: 7507-7517
17. Mertens G, Cassiman JJ, Van den Berghe H, Vermylen J, David G (1992) Cell surface heparan sulfate proteoglycans from human vascular endothelial cells. J Biol Chem 267: 20435-20443
18. Murata K, Yokoyama Y (1989) Acidic glycosaminoglycans in human atherosclerotic cerebral arterial tissues. Atherosclerosis 78: 69-79
19. Nakamura M, Torii S, Yatsuki K, Kikuchi Y, Yamamoto H (1971) Cerebral atherosclerosis in Japanese. - 1. Lipids and glycosaminoglycans in cerebral arteries. Atherosclerosis 13: 185-197
20. Nakashima Y, Kuroiwa A, Nakamura M (1985) Silicon contents in normal, fatty streaks and atheroma of human aortic intima: its relationship with glycosaminoglycans. Br J Exp Pathol 66: 123-127
21. Riessen R, Isner JM, Blessing E, Loushin C, Nikol S, Wight TN (1994) Regional differences in the distribution of the proteoglycans biglycan and decorin in the extracellular matrix of atherosclerotic and restenotic human coronary arteries. Am J Pathol 144: 962-974
22. Ross R (1993) The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 362: 801-809
23. Sambandam T, Baker JR, Christner JE, Ekborg SL (1991) Specifity of the low density lipoprotein-glycosaminoglycan interaction. ArteriosclerThromb 11 (3): 561-568
24. Schmidt A, Buddecke E (1988) Cell-associated proteoheparan sulfate from bovine arterial smooth muscle cells. Exp Cell Res 178: 242-253
25. Schmidt A, Lemming G, Yoshida K, Buddecke E (1992) Molecular organization and antiproliferative domains of arterial tissue heparan sulfate. Eur J Cell Biol 59: 322-328
26. Schmidt A, Skaletz-Rorowski A, Breithardt G, Buddecke E (1995) Growth status-dependent changes of bFGF compartmentalization and heparan sulfate structure in arterial smooth muscle cells. Eur J Cell Biol 67: 130-135
27. Schmidt A, Yoshida K, Buddecke E (1992) The antiproliferative activity of arterial heparan sulfate resides in domains enriched with 2-O-sulfated uronic acid residues. J Biol Chem 267: 19242-19247
28. Shworak NW, Shirakawa M, Colliec-Jouault S, Liu J, Mulligan RC, Birinyi LK, Rosenberg RD (1994) Pathway-specific regulation of the synthesis of anticoagulantly active heparan sulfate. J Biol Chem 269 (40): 24941-24952
29. Stary CH, Chandler AB, Dinsmore RE, Fuster V, Glagow S, Insull W Jr, Rosenfeld ME, Schwartz CJ, Wagner WD, Wissler RW (1995) A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis: a report from the committee on vascular lesions of the Council on Arteriosclerosis, American Heart Association. Circulation 92: 1355-1374
30. Stary HC, Chandler AB, Glagow S, Guyton JR, Insull WJr, Rosenfeld ME, Schaffer A, Schwartz CJ, Wagner WD, Wissler RW (1994) A definition of initial, fatty streak, and intermediate lesions of atherosclerosis: a report from the committee on vascular lesions of the Council on Arteriosclerosis, American Heart Association. Special report. Arterioscler Thromb 14: 840-856
31. Stevens RL, Colombo M, Gonzales JJ, Hollander W, Schrnid K (1976) The glycosaminoglycans of the human artery and their changes in atherosclerosis. J Clin Invest 58: 470-481
32. Vijayagopal P (1994) Regulation of the metabolism of lipoprotein-proteoglycan complexes in human monocyte-derived macrophages. Biochem J 301: 675-681
33. Vijayagopal P, Srinivasan SR, Radhakrishnamurthy B, Berenson GS (1993) Human monocyte-derived macrophages bind low-density-lipoprotein-proteoglycan complexes by a receptor different from the low-density-lipoprotein receptor. Biochem J 289 (Pt3): 837-844
34. Völker W, Schmidt A, Buddecke E (1987) Mapping of proteoglycans in human arterial tissue. Eur J Cell Biol 45: 72-79
35. Völker W, Schmidt A, Buddecke E (1989) Cytochemical changes in a human arterial proteoglycan related to atherosclerosis. Atherosclerosis 77: 117-130
36. Völker W, Schmidt A, Oortmann W, Broszey T, Faber V, Buddecke E (1990) Mapping of proteoglycans in atherosclerotic lesions. Eur Heart J 11: 29-40
37. Wagner WD (1985) Proteoglycan structure and function as related to atherosclerosis. Ann NY Acad Sci 454: 52-68
38. Wagner WD, Salisbury BGJ, Rowe HA (1986) A proposed structure of chondroitin 6-sulfate proteoglycan of human normal and adjacent atherosclerotic plaque. Arteriosclerosis 6: 407-417
39. Wight TN (1989) Cell biology of arterial proteoglycans. Arteriosclerosis 9: 1-20
40. Wight TN (1995) The vascular extracellular matrix. In: Fuster V, Ross R, Topol E (eds) Atherosclerosis and coronary artery disease. Raven Press Ltd, New York
41. Williams KJ, Tabas I (1995) The response to retention hypothesis. Arterioscler Thromb 15: 551-561
42. Yao LY, Moody C, Schönherr E, Wight TN, Sandell LJ (1994) Identification of the proteoglycan versican in aorta and smooth muscle cells by DNA sequence analysis, in situ hybridization and immunocytochemistry. Matrix Biol 14: 213-225
43. Ylä Herttuala S, Sumuvuori H, Karkola K, Möttönen M, Nikkari T (1986) Glycosaminoglycans in normal and atherosclerotic human coronary arteries. Lab Invest 54 (4): 402-407